Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Therapeutic Drug Monitoring: Affecting Factors
Phase II Reactions: Methylation Reactions
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drugs that Destabilize Microtubules
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 16, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
1Diana R. Mager, DNP, RN-BC, is an Assistant Professor, Fairfield University School of Nursing, Fairfield, Connecticut, and a Home Care Nurse and Consultant, Visiting nurse and Hospice of Fairfield County, Norwalk, Connecticut.
This article provides healthcare professionals with essential information on Methotrexate, covering its diverse applications, proper dosing, and potential adverse effects for safe patient management.
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: